Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
Quick Stats
Jun 15, 202652.7
AI Score
HOLD0.25
Volume Ratio
May 11, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
ENTA Stock Summary
Last updated Jun 15, 2026
ENTA is currently trading at $11.58, positioned below its 200-day moving average of $12.64, suggesting bearish momentum. The stock has a 52-week range of $6.435 to $17.15.
Technical Analysis: The 50-day moving average stands at $13.45, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.198, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.279, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ENTA at 52.7/100 with a HOLD recommendation.
ENTA (Enanta Pharmaceuticals, Inc) Indicators
Last updated Jun 15, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.198 |
| CMF (20) | -0.279 |
| ROC (10) | -6.867 |
| ADX (14) | 17.817 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.601 |
| AROONOSC (14) | -64.286 |
| WILLAMS %R (14) | -68.562 |
| MFI (14) | 26.518 |
ENTA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ENTA Price vs Max Options Open Interest
ENTA Max Change In Options Open Interest
ENTA Options - Sort by Max open Interest (near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ENTA Daily Out of Money Options - Sort by Max open Interest (near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ENTA Daily In the Money Options - Sort by Max open Interest (near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ENTA Most Active Options by Volume(near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Enanta Pharmaceuticals, Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ENTA Moving Averages Analysis
ENTA (Enanta Pharmaceuticals, Inc) Simple Moving Averages
Moving Averages are last updated Jun 15, 2026
| Days | MA |
|---|---|
| 10 | 11.54 |
| 20 | 12.49 |
| 30 | 13.19 |
| 50 | 13.45 |
| 100 | 13.43 |
| 200 | 12.64 |
ENTA Fundamental Analysis
| P/E (Forward) | 44.0529 |
| P/E (Trailing) | -- |
| Market Cap ($) | 334.7 million |
| Earnings/Share ($) | -2.6 |
| Net Proft Margin (%) | -0.8956 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.938 |
| EPS Estimate Next Year ($) | -1.955 |
| WallStreet Target Price ($) | 20.1429 |
| Most Recent Quarter |